Comparison of HLA-identical sibling bone marrow transplants (BMT) versus interferon plus cytarabine (IFN/Ara-C) for chronic myelogenous leukemia (CML) in chronic phase (CP).

被引：0
|
作者：
Guilhot, F
Sobocinski, K
Guilhot, J
Zhang, M
Giralt, S
Harousseau, JL
Michallet, M
Maloisel, F
Blaise, D
Guerci, A
Horowitz, M
机构：
[1] CHRU, France Intergrp LMC, Poitiers, France
[2] Med Coll Wisconsin, Int Bone Marrow Transplant Registry, Milwaukee, WI 53226 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2343
引用
收藏
页码：545A / 545A
页数：1
相关论文
共 50 条
  • [41] Treatment of Philadelphia chromosome positive chronic phase chronic myelogenous leukemia (Ph plus CML) with pegylated interferon alpha 2B (Peg-IFN/SCH54031) and low-dose cytosine arabinoside (ara-C)
    Manero, GG
    Talpaz, M
    Giles, F
    Cortes, J
    O'Brien, S
    Faderl, S
    Thomas, D
    Rios, MB
    Kantarjian, H
    BLOOD, 2001, 98 (11) : 258B - 258B
  • [42] Efficacy of FLAG regimen (Fludarabine plus Ara-C plus G-CSF) in the acute phase of chronic myelogenous leukemia.
    Montillo, M
    Tedeschi, A
    Mele, G
    Capelli, D
    Leoni, P
    Cimino, R
    Ferrara, F
    Morra, E
    BLOOD, 1997, 90 (10) : 4006 - 4006
  • [43] Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-c therapy
    Straetmans, N
    Ma, DDF
    Nevell, DF
    Arthur, C
    HEMATOPATHOLOGY AND MOLECULAR HEMATOLOGY, 1996, 10 (04) : 213 - 222
  • [44] Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis
    Qayed, Muna
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen
    Arora, Mukta
    Couriel, Daniel
    Alousi, Amin
    Pidala, Joseph
    Abdel-Azim, Hisham
    Aljurf, Mahmoud
    Ayas, Mouhab
    Bitan, Menachem
    Cairo, Mitchell
    Choi, Sung Won
    Dandoy, Christopher
    Delgado, David
    Gale, Robert Peter
    Hale, Gregory
    Frangoul, Haydar
    Kamble, Rammurti T.
    Kharfan-Dabaja, Mohamed
    Lehman, Leslie
    Levine, John
    MacMillan, Margaret
    Marks, David I.
    Nishihori, Taiga
    Olsson, Richard F.
    Hematti, Peiman
    Ringden, Olov
    Saad, Ayman
    Satwani, Prakash
    Savani, Bipin N.
    Schultz, Kirk R.
    Seo, Sachiko
    Shenoy, Shalini
    Waller, Edmund K.
    Yu, Lolie
    Horowitz, Mary M.
    Horan, John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : 521 - 528
  • [45] METHOTREXATE, CYCLOSPORINE, OR BOTH TO PREVENT GRAFT-VERSUS-HOST DISEASE AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR EARLY LEUKEMIA
    RINGDEN, O
    HOROWITZ, MM
    SONDEL, P
    GALE, RP
    BIGGS, JC
    CHAMPLIN, RE
    DEEG, HJ
    DICKE, K
    MASAOKA, T
    POWLES, RL
    RIMM, AA
    ROZMAN, C
    SOBOCINSKI, KA
    SPECK, B
    ZWAAN, FE
    BORTIN, MM
    BLOOD, 1993, 81 (04) : 1094 - 1101
  • [46] A PHASE-II STUDY OF MITOXANTRONE AND HIGH-DOSE ARA-C (HD ARA-C) IN RELAPSED ACUTE-LEUKEMIA AND BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA (CML-BC)
    WALTERS, R
    KANTARJIAN, H
    KEATING, M
    MCCREDIE, K
    ESTEY, E
    BERAN, M
    ANDERSSON, B
    FREIREICH, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 195 - 195
  • [47] Sudden elastic phase (SBP) transformation in the first 2 years (yrs) of interferon-α (IFN) therapy (RX) for chronic phase (CP) chronic myelogenous leukemia (CML).
    Thomas, D
    Kantarjian, H
    O'Brien, S
    Cortes, J
    Giles, FJ
    Faderl, S
    Rios, M
    Keating, M
    Talpaz, M
    BLOOD, 1998, 92 (10) : 251A - 251A
  • [48] Adjuvant treatment with alfa interferon (IFN) for patients at high risk for relapse after allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML): A preliminary report.
    Higano, C
    Chielens, D
    Radich, J
    Flowers, M
    Appelbaum, F
    BLOOD, 1998, 92 (10) : 654A - 654A
  • [49] ALLOGENIC BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA - RESULTS OF HLA-IDENTICAL TRANSPLANTS IN THE GERMAN-FEDERAL-REPUBLIC
    SCHMITZ, N
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 115 (24) : 923 - 929
  • [50] RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION
    ATKINSON, K
    HOROWITZ, MM
    GALE, RP
    VANBEKKUM, DW
    GLUCKMAN, E
    GOOD, RA
    JACOBSEN, N
    KOLB, HJ
    RIMM, AA
    RINGDEN, O
    ROZMAN, C
    SOBOCINSKI, KA
    ZWAAN, FE
    BORTIN, MM
    BLOOD, 1990, 75 (12) : 2459 - 2464
12345